iRhythm Technologies, Inc. (IRTC)
NASDAQ: IRTC · Real-Time Price · USD
105.92
-2.41 (-2.22%)
At close: Apr 3, 2025, 4:00 PM
105.71
-0.21 (-0.20%)
Pre-market: Apr 4, 2025, 4:47 AM EDT
iRhythm Technologies Market Cap
iRhythm Technologies has a market cap or net worth of $3.33 billion as of April 3, 2025. Its market cap has increased by 4.99% in one year.
Market Cap
3.33B
Enterprise Value
3.53B
1-Year Change
4.99%
Ranking
Category
Stock Price
$105.92
Market Cap Chart
Since October 20, 2016, iRhythm Technologies's market cap has increased from $525.70M to $3.33B, an increase of 532.85%. That is a compound annual growth rate of 24.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2025 | 3.40B | 20.57% |
| Dec 31, 2024 | 2.82B | -13.98% |
| Dec 29, 2023 | 3.28B | 16.32% |
| Dec 30, 2022 | 2.82B | -18.56% |
| Dec 31, 2021 | 3.46B | -49.43% |
| Dec 31, 2020 | 6.85B | 277.77% |
| Dec 31, 2019 | 1.81B | 7.90% |
| Dec 31, 2018 | 1.68B | 30.44% |
| Dec 29, 2017 | 1.29B | 94.05% |
| Dec 30, 2016 | 663.80M | 26.27% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 723.09B |
| UnitedHealth Group | 478.50B |
| Johnson & Johnson | 369.31B |
| AbbVie | 364.89B |
| Novo Nordisk | 307.98B |
| Abbott Laboratories | 228.39B |
| AstraZeneca | 227.81B |
| Merck & Co. | 220.07B |